May 18, 2020 – Funding
NCI would like to increase the number of P01 grants in its portfolio. The NCI Office of Cancer Centers is offering supplemental funding to the P30 Cancer Center Support Grant (CCSG) for the purpose of stimulating the...
Funding
DF/HCC offers a variety of funding opportunities to members to encourage and enhance the collaborative spirit of research within the Harvard-affiliated medical community. Annual funding opportunities through DF/HCC have historically included pilot project awards through our Cancer Center development funding budget, SPORE career and project development awards, and jointly sponsored funding opportunities made available through our many partnerships with entities such as the Harvard Catalyst, the U54 DF/HCC UMass Boston Partnership, and the Harvard University Center for AIDs Research.
Two important funding programs have provided substantial opportunities to DF/HCC investigators recently. The Bridge Project, a collaboration between DF/HCC and the Koch Institute for Cancer Research at MIT, offers funding for teams that bring bioengineering, advanced cancer science, and clinical oncology together to address unmet clinical needs and technological solutions. The A. David Mazzone Research Awards Program funds a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases.
Funding Opportunities & Archive
-
-
May 18, 2020 – Funding
The DF/HCC Breast Cancer Program has released RFA's for its Breast SPORE Career Enhancement and Developmental Research Project Awards, with applications due on June 12, 2020. Read more about these awards below for more...
-
May 04, 2020 – Funding
An additional Childhood Cancer Data Initiative (CCDI) P30 supplement announcement has been released. DF/HCC has the opportunity to nominate one application for this supplement, and as such requires an internal vetting...
-
April 22, 2020 – Funding
Due on June 15, 2020 with informational webinar on 4/28 at 4pm
-
April 14, 2020 – Funding
NCI Notice of Special Interest for Competitive Revisions and Administrative Supplements for COVID-19
The NCI has Published a NOSI for competitive revisions and administrative supplements for COVID-19 research. The potential for immediate impact, cancer relevance, and feasibility will be important considerations for...